Financhill
Back

Equifax Vs. Ultragenyx Pharmaceutical Industry Stock Comparison

Buy
55

EFX
Equifax

Last Price:
239.73
Seasonality Move:
-1.36%
Sell
43

RARE
Ultragenyx Pharmaceutical

Last Price:
39.58
Seasonality Move:
3.65%
Buy
55
Equifax (EFX) is a Buy

Is Equifax a Buy, Sell or Hold?

  • The current Equifax [EFX] share price is $239.74. The Score for EFX is 55, which is 10% above its historic median score of 50, and infers lower risk than normal.
  • EFX is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
43
Ultragenyx Pharmaceutical (RARE) is a Sell

Is Ultragenyx Pharmaceutical a Buy, Sell or Hold?

  • The current Ultragenyx Pharmaceutical [RARE] share price is $39.60. The Score for RARE is 43, which is 14% below its historic median score of 50, and infers higher risk than normal.
  • RARE is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

EFX Stock Price Chart

What is Equifax's stock price today?

  • The Equifax share price today is $239.74
    The current trend is relatively stagnant and EFX is experiencing buying pressure, which is a positive indicator for future bullish movement.

RARE Stock Price Chart

What is Ultragenyx Pharmaceutical's stock price today?

  • The Ultragenyx Pharmaceutical share price today is $39.60
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and RARE is experiencing buying pressure, which is a positive indicator for future bullish movement.

EFX Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.59 Buy
Relative Strength Index (14 RSI): 51.32 Buy
Chaikin Money Flow: 929057 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (232.73 - 244.83) Buy
Bollinger Bands (100): (232.76 - 261.64) Sell

RARE Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.73 Sell
Relative Strength Index (14 RSI): 45.77 Sell
Chaikin Money Flow: 722527 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (38.99 - 42.29) Sell
Bollinger Bands (100): (41.03 - 48.83) Sell

EFX Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 240.17 Sell
20-day SMA: 236.95 Buy
50-day SMA: 235.64 Buy
200-day SMA: 227.97 Buy
8-day EMA: 239.68 Buy
20-day EMA: 238.63 Buy
50-day EMA: 239.75 Sell
200-day EMA: 232.94 Buy

RARE Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 40.38 Sell
20-day SMA: 40.41 Sell
50-day SMA: 41.94 Sell
200-day SMA: 42.46 Sell
8-day EMA: 39.76 Sell
20-day EMA: 40.54 Sell
50-day EMA: 42.03 Sell
200-day EMA: 43.46 Sell

Equifax Earnings Growth & EFX Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.24 per share, an increase next quarter of $0.24 per share, an increase this year of $0.73 per share, and an increase next year of $2.14 per share.

Ultragenyx Pharmaceutical Earnings Growth & RARE Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.49 per share, an increase next quarter of $0.01 per share, an increase this year of $0.90 per share, and an increase next year of $1.07 per share.

Equifax Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Ultragenyx Pharmaceutical Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):